|Bid||1.2900 x 2200|
|Ask||1.3100 x 1800|
|Day's Range||1.2900 - 1.3300|
|52 Week Range||1.0200 - 3.1300|
|Beta (3Y Monthly)||1.01|
|PE Ratio (TTM)||0.79|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.85|
If you own shares in IVERIC bio, Inc. (NASDAQ:ISEE) then it's worth thinking about how it contributes to the...
IVERIC bio (ISEE) first-quarter earnings beat estimates. The company is focusing on developing gene therapies for treating inherited retinal diseases.
On a per-share basis, the New York-based company said it had a loss of 30 cents. The company's shares closed at $1.44. A year ago, they were trading at $2.63. _____ This story was generated by Automated ...
IVERIC bio today announced that it will report its first quarter 2019 financial and operating results on Wednesday, May 8, 2019. Following the announcement, IVERIC bio’s management team will host a live conference call and webcast at 8:00 a.m.